These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3318051)

  • 1. Enzymuria in carboplatin nephrotoxicity.
    Damiani E; Cattaneo MT; Sessa C; Zucca E; Cavalli F; Bertolini A; Libretti A; Beretta R
    Tumori; 1987 Oct; 73(5):487-91. PubMed ID: 3318051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
    Goren MP; Forastiere AA; Wright RK; Horowitz ME; Dodge RK; Kamen BA; Viar MJ; Pratt CB
    Cancer Chemother Pharmacol; 1987; 19(1):57-60. PubMed ID: 2880677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9).
    Skillen AW; Buamah PK; Cantwell BM; Cornell C; Hodson AW; Harris AL
    Cancer Chemother Pharmacol; 1988; 22(3):228-34. PubMed ID: 3044631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of renal enzymes to evaluate nephrotoxicity in lithium treated patients.
    Garvey MJ; Tuason VB; Blomquist CH; Hwang S
    Br J Psychiatry; 1982 Oct; 141():420-2. PubMed ID: 7171913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzymuria and kidney diseases in childhood].
    Ehrich JH; Wurster U; Lütge M; Doehring E; Oemar B
    Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations on the acute and chronic nephrotoxicity of the new platinum analogue carboplatin.
    Metz-Kurschel U; Kurschel E; Niederle N; Aulbert E
    J Cancer Res Clin Oncol; 1990; 116(2):203-6. PubMed ID: 2182639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
    Hsu WS; Kao JT; Chen JS
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
    Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
    Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of N-acetyl-beta-D-glucosaminidase (NAG) determination in assessing netilmicin nephrotoxicity in preterm babies.
    Langhendries JP; Mattot M; François A; Deprez D; Battisti O; Bertrand JM; Schoos S
    Biol Neonate; 1989; 56(2):76-82. PubMed ID: 2790088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease.
    Kunin CM; Chesney RW; Craig WA; England AC; DeAngelis C
    Pediatrics; 1978 Nov; 62(5):751-60. PubMed ID: 364392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside nephrotoxicity and urinary excretion of N-acetyl-beta-D-glucosaminidase.
    Langhendries JP; Battisti O; Bertrand JM
    Biol Neonate; 1988; 53(4):253-9. PubMed ID: 3046671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 6. Preclinical evaluation of the urinary NAG activity and its relation to kidney function tests].
    Sano K; Uno E
    Rinsho Byori; 1983 Sep; Spec No 56():111-21. PubMed ID: 6663752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 8. Preclinical evaluation of the urinary NAG activities and their fluctuations in kidney diseases].
    Ishida M; Fujino N; Maeba T; Sugiyama M; Kanazawa T; Owada S; Inoue T; Ozawa S; Amakawa T
    Rinsho Byori; 1983 Sep; Spec No 56():132-8. PubMed ID: 6663754
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary N-acetyl-beta-D-glucosaminidase as an indicator of tubular damage in multiple myeloma.
    Coward RA; DeLamore IW; Mallick NP; Robinson LE
    Clin Chim Acta; 1984 Apr; 138(3):293-8. PubMed ID: 6426824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases].
    Yakata M; Sugita O; Sakai T; Uchiyama K; Wada K
    Rinsho Byori; 1983 Sep; Spec No 56():90-101. PubMed ID: 6663765
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.
    Donta ST; Lembke LA
    Antimicrob Agents Chemother; 1985 Oct; 28(4):500-3. PubMed ID: 4073872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 1. Description of NAG activity determination].
    Noto A; Mori S; Nakamura M; Kitakaze T
    Rinsho Byori; 1983 Sep; Spec No 56():65-72. PubMed ID: 6663762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium--N-acetyl-beta-D-glucosaminidase. 11. Clinical significance of urinary NAG activity in patients with kidney diseases and those with kidney homografts].
    Ishida Y; Kawada T; Sugino N
    Rinsho Byori; 1983 Sep; Spec No 56():160-7. PubMed ID: 6363758
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
    Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
    Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.